Kuhle J - Search Results

1

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis.

Kaufmann M, Puhan MA, Kuhle J, Yaldizli Ö, Magnusson T, Kamm CP, Calabrese P, von Wyl V. Kaufmann M, et al. Among authors: kuhle j. Front Neurol. 2019 Sep 4;10:953. doi: 10.3389/fneur.2019.00953. eCollection 2019. Front Neurol. 2019. PMID: 31555205 Free PMC article.

2

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RL, Kappos L. Mehling M, et al. Among authors: kuhle j. Neurology. 2008 Oct 14;71(16):1261-7. doi: 10.1212/01.wnl.0000327609.57688.ea. Neurology. 2008. PMID: 18852441

3

Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.

Mehling M, Lindberg R, Raulf F, Kuhle J, Hess C, Kappos L, Brinkmann V. Mehling M, et al. Among authors: kuhle j. Neurology. 2010 Aug 3;75(5):403-10. doi: 10.1212/WNL.0b013e3181ebdd64. Epub 2010 Jun 30. Neurology. 2010. PMID: 20592255

4

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.

Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RL. Kuhle J, et al. Neurology. 2011 Apr 5;76(14):1206-13. doi: 10.1212/WNL.0b013e31821432ff. Epub 2011 Feb 23. Neurology. 2011. PMID: 21346223

5

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Kuhle J, Gosert R, Bühler R, Derfuss T, Sutter R, Yaldizli O, Radue EW, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH. Kuhle J, et al. Neurology. 2011 Dec 6;77(23):2010-6. doi: 10.1212/WNL.0b013e31823b9b27. Epub 2011 Nov 9. Neurology. 2011. PMID: 22076540 Free PMC article.

6

Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.

Gensicke H, Leppert D, Yaldizli Ö, Lindberg RL, Mehling M, Kappos L, Kuhle J. Gensicke H, et al. Among authors: kuhle j. CNS Drugs. 2012 Jan 1;26(1):11-37. doi: 10.2165/11596920-000000000-00000. CNS Drugs. 2012. PMID: 22171583 Review.

7

Screening for balance disorders in mildly affected multiple sclerosis patients.

Fanchamps MH, Gensicke H, Kuhle J, Kappos L, Allum JH, Yaldizli O. Fanchamps MH, et al. Among authors: kuhle j. J Neurol. 2012 Jul;259(7):1413-9. doi: 10.1007/s00415-011-6366-5. Epub 2011 Dec 21. J Neurol. 2012. PMID: 22186852

8

Balance control in multiple sclerosis: correlations of trunk sway during stance and gait tests with disease severity.

Corporaal SH, Gensicke H, Kuhle J, Kappos L, Allum JH, Yaldizli Ö. Corporaal SH, et al. Among authors: kuhle j. Gait Posture. 2013 Jan;37(1):55-60. doi: 10.1016/j.gaitpost.2012.05.025. Epub 2012 Aug 5. Gait Posture. 2013. PMID: 22874664

9

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.

Kuhle J, Malmeström C, Axelsson M, Plattner K, Yaldizli O, Derfuss T, Giovannoni G, Kappos L, Lycke J. Kuhle J, et al. Acta Neurol Scand. 2013 Dec;128(6):e33-6. doi: 10.1111/ane.12151. Epub 2013 Jun 13. Acta Neurol Scand. 2013. PMID: 23763388

10

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.

Papadopoulou A, Menegola M, Kuhle J, Ramagopalan SV, D'Souza M, Sprenger T, Radue EW, Kappos L, Yaldizli Ö. Papadopoulou A, et al. Among authors: kuhle j. Mult Scler. 2014 Mar;20(3):322-30. doi: 10.1177/1352458513495583. Epub 2013 Jul 11. Mult Scler. 2014. PMID: 23846352 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters